Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PYX-106 |
| Trade Name | |
| Synonyms | PYX 106|PYX106|BSI-060T|BSI 060T|BSI060T |
| Drug Descriptions |
PYX-106 (BSI-060T) is an antibody that targets Siglec-15, potentially resulting in increased T cell proliferation and cytokine release and decreased tumor growth (Cancer Res (2022) 82 (12_Supplement): 5522). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| PYX-106 | PYX-106 | 0 | 1 |